TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription
Jinmei Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhuowei Hu(Capital Normal University), Shuang Shang(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Hua(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiaojiao Yu(Fujian Medical University), Bing Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Ke Li(Nanchang University), Xiaowei Zhang(Central Hospital of Zibo), Shanshan Liu(Guangdong Province Women and Children Hospital), Feng Wang(First Affiliated Hospital of Bengbu Medical College), Wei Sun(Ganzhou People's Hospital), Pingping Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Bo Huang(Guangdong Pharmaceutical University), Yuying Liu(Tianjin University of Science and Technology), Xiaoxi Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhao-na Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xueying Hou(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhenhe Wang(Shandong University of Technology), Xiao Liang(Harbin Medical University)
Cited by 254
Related Papers
The regulation of β-catenin activity and function in cancer: therapeutic opportunities
|Oncotarget|2017|632
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
|Science Immunology|2020|555
Tumor-Repopulating Cells Induce PD-1 Expression in CD8+ T Cells by Transferring Kynurenine and AhR Activation
|Cancer Cell|2018|535
Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
|Nature Communications|2018|520
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
|Science Translational Medicine|2020|447